Related Experiment Video
Updated: Sep 18, 2025

09:01
Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
262
Vitacrystallography: Appearance and Development of Cancer-Induced Structural Biomarkers in a Mouse Model
Oleksii Avdieiev1, Sergey A Denisov1,2, Ashkan Ajeer3
1EosDx UK Ltd., 5 New Street Square, London EC4A 3TW, UK.
Life (Basel, Switzerland)
|June 26, 2025
Summary
Researchers discovered a new structural biomarker for prostate cancer using X-ray scattering. This biomarker, based on lipid and water ratios, tracks cancer progression and can aid in early disease detection and monitoring treatment effectiveness.
Area of Science:
- Biophysics
- Medical Imaging
- Oncology
Background:
- Conventional diagnostics for diseases like prostate cancer can be complemented by structural biomarkers.
- X-ray scattering offers a method for identifying these biomarkers within tissues.
Purpose of the Study:
- To investigate the potential of X-ray scattering for detecting and monitoring prostate cancer progression.
- To identify a novel structural biomarker for prostate cancer in mouse models.
Main Methods:
- Prostate cancer was induced in mouse models, with one lobe inoculated and the other left as a control.
- Tissue samples were collected at various time points and analyzed using X-ray scattering.
- Structural changes were assessed by examining the ratio of X-ray scattering peaks related to lipids and water.
Main Results:
- A distinct ratio between X-ray scattering peaks for lipids and water was identified as a structural biomarker for prostate cancer.
- This biomarker demonstrated a developmental trajectory that correlated with tumor advancement.
- The biomarker's progression along its trajectory indicated disease progression or healing.
Conclusions:
- The lipid-to-water X-ray scattering ratio serves as a viable structural biomarker for prostate cancer.
- This biomarker can be used to establish a baseline for disease staging and monitor treatment efficacy.
- X-ray scattering analysis provides a pathway for early disease detection and personalized patient management.

